PURPOSE OF REVIEW: This review details the role of memory T cells in physiologic and allospecific immunity, and summarizes the effects of immunosuppressive agents used to manipulate their function in the context of organ transplantation. RECENT FINDINGS: Memory T cells are lymphocytes with characteristics that are thought to promote anamnestic immune responses. They have a unique capacity to generate rapid effector functions upon secondary exposure to a pathogen, and this capacity is achieved through truncated requirements for antigen presentation, reduced activation thresholds, and enhanced trafficking and adhesion mechanisms. In general, these same mechanisms also appear to evoke improved efficiency in mediating allograft rejection. The phenotype of these cells has been increasingly well defined and associated with a characteristic pattern of susceptibility to immunosuppressive agents. This knowledge is now being exploited in the development of immune therapeutic regimens to selectively mollify T memory cell effects. SUMMARY: A specific targeting of memory T cells has potential to prevent allograft rejection in a more precise manner than current means of immunosuppression. However, these benefits will be balanced by the reciprocal risk of susceptibility to recurrent infection.
PURPOSE OF REVIEW: This review details the role of memory T cells in physiologic and allospecific immunity, and summarizes the effects of immunosuppressive agents used to manipulate their function in the context of organ transplantation. RECENT FINDINGS: Memory T cells are lymphocytes with characteristics that are thought to promote anamnestic immune responses. They have a unique capacity to generate rapid effector functions upon secondary exposure to a pathogen, and this capacity is achieved through truncated requirements for antigen presentation, reduced activation thresholds, and enhanced trafficking and adhesion mechanisms. In general, these same mechanisms also appear to evoke improved efficiency in mediating allograft rejection. The phenotype of these cells has been increasingly well defined and associated with a characteristic pattern of susceptibility to immunosuppressive agents. This knowledge is now being exploited in the development of immune therapeutic regimens to selectively mollify T memory cell effects. SUMMARY: A specific targeting of memory T cells has potential to prevent allograft rejection in a more precise manner than current means of immunosuppression. However, these benefits will be balanced by the reciprocal risk of susceptibility to recurrent infection.
Authors: Adam W Bingaman; Deepa S Patke; Vaishali R Mane; Mojgan Ahmadzadeh; Modesta Ndejembi; Stephen T Bartlett; Donna L Farber Journal: Eur J Immunol Date: 2005-11 Impact factor: 5.532
Authors: Jonathan P Pearl; Jeremy Parris; Douglas A Hale; Steven C Hoffmann; Wendy B Bernstein; Kelly L McCoy; S John Swanson; Roslyn B Mannon; Mario Roederer; Allan D Kirk Journal: Am J Transplant Date: 2005-03 Impact factor: 8.086
Authors: Minh Diem Vu; Michael R Clarkson; Hideo Yagita; Laurence A Turka; Mohamed H Sayegh; Xian Chang Li Journal: J Immunol Date: 2006-02-01 Impact factor: 5.422
Authors: Dominic C Borie; Paul S Changelian; Michael J Larson; Ming-Sing Si; Ricardo Paniagua; John P Higgins; Bari Holm; Andrew Campbell; Macy Lau; Sally Zhang; Mona G Flores; Geraldine Rousvoal; Jennifer Hawkins; Douglas A Ball; Elizabeth M Kudlacz; William H Brissette; Eileen A Elliott; Bruce A Reitz; Randall E Morris Journal: Transplantation Date: 2005-04-15 Impact factor: 4.939
Authors: Allan D Kirk; Roslyn B Mannon; David E Kleiner; John S Swanson; Robert L Kampen; Linda K Cendales; Eric A Elster; Terri Wakefield; Christine Chamberlain; Steven C Hoffmann; Douglas A Hale Journal: Transplantation Date: 2005-10-27 Impact factor: 4.939
Authors: Flavio Vincenti; Christian Larsen; Antoine Durrbach; Thomas Wekerle; Björn Nashan; Gilles Blancho; Philippe Lang; Josep Grinyo; Philip F Halloran; Kim Solez; David Hagerty; Elliott Levy; Wenjiong Zhou; Kannan Natarajan; Bernard Charpentier Journal: N Engl J Med Date: 2005-08-25 Impact factor: 91.245
Authors: Krista G Haanstra; Ella A Sick; Jan Ringers; Jacqueline A M Wubben; Eva-Maria Kuhn; Louis Boon; Margreet Jonker Journal: Transplantation Date: 2005-06-15 Impact factor: 4.939
Authors: Amanda L Marzo; Kimberly D Klonowski; Agnes Le Bon; Persephone Borrow; David F Tough; Leo Lefrançois Journal: Nat Immunol Date: 2005-07-17 Impact factor: 25.606
Authors: Zachary Fitch; Robin Schmitz; Jean Kwun; Bernhard Hering; Joren Madsen; Stuart J Knechtle Journal: Transplant Rev (Orlando) Date: 2019-04-05 Impact factor: 3.943
Authors: K P Samy; D J Anderson; D J Lo; M S Mulvihill; M Song; A B Farris; B S Parker; A L MacDonald; C Lu; T A Springer; S C Kachlany; K A Reimann; T How; F V Leopardi; K S Franke; K D Williams; B H Collins; A D Kirk Journal: Am J Transplant Date: 2017-01-27 Impact factor: 8.086
Authors: D J Lo; D J Anderson; T A Weaver; F Leopardi; M Song; A B Farris; E A Strobert; J Jenkins; N A Turgeon; A K Mehta; C P Larsen; A D Kirk Journal: Am J Transplant Date: 2013-01-11 Impact factor: 8.086